Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cerebral Small Vessel Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06960538
What this trial is testing

Enpowering Progression Risk of Cerebral Amyloid Angiopathy

Who this might be right for
Cerebral Amyloid AngiopathyCAA - Cerebral Amyloid Angiopathy
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 200
Not applicableEnded earlyNCT01586858
What this trial is testing

Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study

Who this might be right for
Granulomatosis With PolyangiitisMicroscopic Polyangiitis
Johns Hopkins University 67
Not applicableStudy completedNCT01165697
What this trial is testing

Establishment of Biomarkers for Fabry Disease

Who this might be right for
Fabry Disease
Ohio State University 4
Not applicableEnded earlyNCT04011202
What this trial is testing

Virtual Reality, Mood, and Sedentary Behaviour After Stroke

Who this might be right for
StrokeStroke, IschemicStroke Hemorrhagic+1 more
University of British Columbia 28
Not applicableNot Yet RecruitingNCT07485660
What this trial is testing

Care Pathway for Patients With Fabry's Disease (Fabry-PATH)

Who this might be right for
Fabry Disease
University Hospital, Toulouse 200
Not applicableStudy completedNCT02908724
What this trial is testing

Cardiac Involvement in Adult Patients With Fabry Disease; Relation to Enzyme Replacement Therapy

Who this might be right for
Fabry Disease
Ulla Feldt-Rasmussen 66
Early research (Phase 1)Study completedNCT02223052
What this trial is testing

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Who this might be right for
Hematological NeoplasmsNon-Hodgkin's LymphomaHodgkin's Lymphoma+17 more
Celgene 89
Not applicableLooking for participantsNCT07374913
What this trial is testing

COL4A1COL4A2: Study of Pathological Conditions Involving Multiple Organs Caused by Mutations in the COL4A1 and COL4A2 Genes

Who this might be right for
COL4A1\2COL4A1-Related Brain Small Vessel Disease With Haemorrhage
Meyer Children's Hospital IRCCS 120
Not applicableStudy completedNCT05746624
What this trial is testing

Procedural Motor Memory in Long COVID-19

Who this might be right for
Infectious Metabolic EncephalopathyIschemic StrokeSeizure+1 more
National Institute of Neurological Disorders and Stroke (NINDS) 333
Not applicableStudy completedNCT01268241
What this trial is testing

The Efficacy and Safety of Switch Between Agalsidase Beta to Agalsidase Alfa for Enzyme Replacement in Patients With Anderson-Fabry Disease

Who this might be right for
Fabry DiseaseFabry´s DiseaseAnderson-Fabry Disease
CENTOGENE GmbH Rostock 200
Testing effectiveness (Phase 2)Study completedNCT01678898
What this trial is testing

Dose-ranging Study of PRX-102 in Adult Fabry Disease Patients

Who this might be right for
Fabry Disease
Protalix 18
Post-approval studies (Phase 4)Study completedNCT05054387
What this trial is testing

China Post-marketing Surveillance (PMS) Study of Fabrazyme®

Who this might be right for
Fabry Disease
Genzyme, a Sanofi Company 22
Not applicableStudy completedNCT00055016
What this trial is testing

Registry of Fabry Disease - A Multicenter Observational Study

Who this might be right for
Fabry Disease
National Institute of Neurological Disorders and Stroke (NINDS) 100
Post-approval studies (Phase 4)Not Yet RecruitingNCT05169021
What this trial is testing

Folic Acid and Intensive Antihypertensive Therapy for Hypertension With CSVD

Who this might be right for
Cerebral Small Vessel DiseasesStroke
Beijing Tiantan Hospital 15,000
Not applicableUnknownNCT05255328
What this trial is testing

Clinical Long Term Evaluation of Glutamine Supplement in MELAS Syndrome

Who this might be right for
MELAS Syndrome
Hospital Universitario 12 de Octubre 9
Large-scale testing (Phase 3)Study completedNCT03566017
What this trial is testing

Open Label Extension Study of 1 mg/kg Pegunigalsidase Alfa Every 2 Weeks in Patients With Fabry Disease

Who this might be right for
Fabry Disease
Chiesi Farmaceutici S.p.A. 97
Not applicableUnknownNCT05719337
What this trial is testing

Multi-Modality Echocardiographic Techniques in Pathological Left Ventricular Hypertrophy Adults

Who this might be right for
Left Ventricular Hypertrophy
First Hospital of China Medical University 660
Not applicableUnknownNCT04816500
What this trial is testing

Remote Ischemic Conditioning on Cerebral Small Vessel Disease

Who this might be right for
Cerebral Small Vessel Diseases
Capital Medical University 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT06961344
What this trial is testing

An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM)

Who this might be right for
Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)
Tisento Therapeutics 44
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Next Page